<DOC>
	<DOCNO>NCT01465451</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety intra-operative chemotherapy 5-FU colorectal cancer patient receive curative resection . The hypothesis intra-operative intervention might best time cancer cell kill cytotoxic agent , residual cancer cell may get rapid growth tumor debulking may become chemotherapy-sensitive . A three-step procedure design intra-operative chemotherapy 5-FU 1500 mg/m2 , include step 1 intraluminal 5-FU injection 1000 mg/m2 begin resection , step 2 200mg/m2 5-FU injection portal vein system via mesentery vein tumor removal finish bowel reconstruction , step 3 300mg/m2 5-FU leave abdominal cavity incision closure . The controlled arm receive curative resection . All treatment stick guideline .</brief_summary>
	<brief_title>Intra-operative Chemotherapy With 5-FU Colorectal Cancer Patients Receiving Curative Resection : Efficacy Safety</brief_title>
	<detailed_description>nil .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>histologically confirm adenocarcinoma colon rectum age 1875 year eligible curative surgical resection performance score : ECOG 01 normal blood cell count : WBC ≥ 4.0×10*9/L，PLT ≥ 100×10*9/L normal blood chemistry test : ALT/AST ≤ 2.5 ULN , TBil ≤ 1.5 ULN , BUN ≤ 1.5 ULN , Cr ≤ 1.5 ULN normal ECG history malignant tumor concomitant anticancer therapy clinical bowel obstruction anticipate another clinical trial within three month uncontrolled infection , serious internal medical disease Pregnant lactate woman mentally abnormal patient patient know allergic 5FU</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>curative resection</keyword>
	<keyword>intra-operative chemotherapy</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>chemotherapy</keyword>
</DOC>